跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Vivax -50
Approved
STANDARD
Vivax -50
Brawn Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7b088a8e6fe3256b
Company
Brawn Laboratories Limited
Type
Standard
Approval Details
Approval Id
7b088a8e6fe3256b
Drug Approval Philippines Name
Vivax -50
Product Name
Vivax -50
Registration Number
DRP-4511
Brand Name
Vivax -50
Generic Name
Sildenafil (as citrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg
Manufacturer
Brawn Laboratories Limited
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
28 September 2022
Expiry Date
18 July 2028
Pharmacologic Category
Urologicals (Drugs used for erectile dysfunction)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7b088a8e6fe3256b
Type
Standard
Back to Philippines FDA Approvals
Vivax -50 - Philippines FDA Drug Approval Details